SCHEDULE 13G/A: T. Rowe Price Associates Discloses 8.1% Stake in Perrigo Co PLC

T. Rowe Price Associates, Inc. has filed an amended Schedule 13G, reporting an 8.1% beneficial ownership stake in Perrigo Co PLC as of March 31, 2025.

Summary

• T. Rowe Price Associates, Inc. reported beneficial ownership of 11,073,026 shares of Perrigo Co PLC common stock.
• This holding represents 8.1% of Perrigo Co PLC's outstanding common stock.
• T. Rowe Price Associates, Inc. holds sole voting power over 11,031,988 shares and sole dispositive power over 11,073,026 shares.
• The filing confirms that the shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of Perrigo Co PLC.

Sentiment

Score: 7

Explanation: The disclosure of a significant stake by a reputable institutional investor like T. Rowe Price is generally viewed positively as it signals confidence in the company's long-term prospects, even though the filing itself is purely factual and not an endorsement.

Positives

• The disclosure of a significant 8.1% stake by T. Rowe Price Associates, Inc., a prominent institutional investor, signals confidence in Perrigo Co PLC's long-term prospects.
• This substantial holding by a major asset manager can be viewed as a positive indicator of institutional support and belief in the company's value.

Risks

• The filing explicitly states that the securities were not acquired for the purpose of changing or influencing control of the issuer, which mitigates immediate corporate governance risks related to this specific holding.

Future Outlook

The document does not provide any forward-looking statements or guidance regarding Perrigo Co PLC's future performance or strategic direction, as it is a disclosure of beneficial ownership by an institutional investor.

Management Comments

• "T. Rowe Price Associates, Inc. certifies that the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities."
• "T. Rowe Price Associates, Inc. hereby declares and affirms that the filing of Schedule 13G shall not be construed as an admission that Price Associates is the beneficial owner of the securities referred to, which beneficial ownership is expressly denied."

Industry Context

This filing reflects a significant investment by a major asset management firm, T. Rowe Price Associates, Inc., in Perrigo Co PLC, a company operating in the consumer health and pharmaceutical sector. Such institutional holdings are common and indicate a fund's strategic allocation within its portfolio, often reflecting a long-term view on the company's prospects within its industry.

Stakeholder Impact

• Shareholders: The disclosure of a significant stake by a major institutional investor may instill confidence among existing and potential shareholders, potentially influencing stock perception.

Key Dates

Keywords

Perrigo Co PLC, T. Rowe Price Associates, Schedule 13G, Beneficial Ownership, Institutional Investor, Common Stock, Equity Stake, Pharmaceuticals, Consumer Health